Zacks Investment Research | Nov 13, 2018 01:47AM ET
Univar Inc.’s (NYSE:UNVR) subsidiary Univar B.V. recently declared that Deinove has appointed Univar as its Phyt-N-Resist distributor in the Europe, Middle East and Africa regions. In order to integrate its promotional and commercial efforts, Deinove chose Univar based on its industry specialization and global technical expertise to serve the beauty and personal care space.
Phyt-N-Resist is a nature-based cosmetic active. It has 100% pure phytoene formulation concentrated in organic jojoba oil. A colorless carotenoid is obtained through a process of fermentation of natural sugars by the extremophilic bacterium Deinococcus geothermalis, Phytoene. It helps fight skin aging by reducing oxidative stress and accelerating skin regeneration.
The agreement will help Univar broaden its product portfolio and diversify into cosmetic actives. Univar offers solid market coverage and industry expertise to partners and suppliers around the world, with access to a large portfolio of personal care, beauty products and solutions.
Phyt-N-Resist helps expand the company’s active offerings, while complementing distribution portfolio of functional specialty ingredients.
In a year’s time, shares of Univar have lost around 25.2% compared with the industry ’s fall of 17.5%.
Univar, in its third-quarter earnings call, said that it expects foreign exchange headwinds and challenges in Canada to dampen growth in the fourth quarter. The company expects fourth-quarter adjusted EBITDA to be flat with last year’s results. The guidance also takes into account demand softness in certain markets.
For 2018, Univar anticipates adjusted EBITDA growth of high single-digit while adjusted earnings per share are projected at roughly $1.60 per share, reflecting an increase of 15.1% from the prior year.
Revenues and gross profit at Univar’s USA and EMEA segments increased year over year in the third quarter. However, sales and gross profit across Canada and Rest of World units declined year over year.
Univar Inc. Price and Consensus
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.